INOVIO PHARMACEUTICALS, INC. Additional Paid in Capital
INOVIO PHARMACEUTICALS, INC. (INO) had Additional Paid in Capital of $1.85 billion as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital $1.85B.
- 2026-03-31: Additional Paid in Capital $1.84B.
- 2025-12-31: Additional Paid in Capital $1.84B.
- 2025-09-30: Additional Paid in Capital $1.81B.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $1.85B 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.84B 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.84B 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.81B 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.80B 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.80B 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.80B 10-K · filed 2026-03-12 | |
| 2024-09-30 | $1.78B 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.78B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.75B 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.74B 10-K · filed 2025-03-18 | |
| 2023-09-30 | $1.74B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.73B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.73B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.71B 10-K · filed 2024-03-06 | $1.71B 10-K · filed 2023-03-01 |
| 2022-09-30 | $1.70B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.69B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.64B 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.61B 10-K · filed 2023-03-01 | |
| 2021-09-30 | $1.56B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.55B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.54B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.37B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.21B 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.09B 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $957.96M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $742.65M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $735.02M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $731.82M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $727.17M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $707.79M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $690.93M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $674.02M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $668.84M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $665.78M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $663.22M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $589.89M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $563.23M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $556.72M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $552.75M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $546.25M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $537.13M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $534.00M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $532.56M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $529.56M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $445.74M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $443.33M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $441.28M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $439.14M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $435.18M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $348.27M 10-K · filed 2015-03-16 | $348.11M 10-K · filed 2014-03-17 |
| 2013-09-30 | $341.98M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $278.57M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $278.29M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $263.90M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $259.64M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $258.11M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $257.84M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $257.24M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $255.24M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $254.96M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $241.23M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |